An FDA advisory panel voted that a long-acting, injectableform of Eli Lilly’s best-sellingdrug, the antipsychotic olanzapine, is safe enough for use insome patients with schizophrenia. But panel members shared concerns raised bythe FDA that Zyprexa LAI wasassociated with excessive sedation.
Product news
An FDA advisory panel voted that a long-acting, injectable form of Eli Lilly's best-selling drug, the antipsychotic olanzapine, is safe enough for use in some patients with schizophrenia.
